180
Participants
Start Date
March 25, 2025
Primary Completion Date
January 28, 2028
Study Completion Date
January 28, 2028
MK-3120
IV infusion
RECRUITING
National Cheng Kung University Hospital ( Site 0161), Tainan City
RECRUITING
Hacettepe Universite Hastaneleri ( Site 0130), Ankara
RECRUITING
National Taiwan University Hospital ( Site 0160), Taipei
RECRUITING
Virginia Commonwealth University ( Site 1008), Richmond
RECRUITING
Hospital Universitario Fundación Jiménez Díaz-START Madrid-FJD ( Site 0111), Madrid
RECRUITING
Hospital Universitario Virgen de la Victoria ( Site 0114), Málaga
RECRUITING
University of Miami Hospital and Clinics, Sylvester Cancer Center ( Site 1003), Miami
RECRUITING
Koc University, School of Medicine ( Site 0133), Istanbul
RECRUITING
Centre Eugène Marquis Rennes - Centre de Lutte Contre le Cancer-Medical Oncology ( Site 0054), Rennes
RECRUITING
The University of Alabama at Birmingham ( Site 1005), Birmingham
RECRUITING
Centre Oscar Lambret ( Site 0051), Lille
RECRUITING
Chi Mei Medical Center ( Site 0162), Tainan City
RECRUITING
Peking University First Hospital ( Site 0180), Beijing
RECRUITING
The First Hospital of Jilin University ( Site 0185), Changchun
RECRUITING
Chongqing Cancer Hospital ( Site 0186), Chongqing
RECRUITING
West China Hospital Sichuan University ( Site 0187), Chengdu
RECRUITING
Rambam Health Care Campus ( Site 0082), Haifa
RECRUITING
Rabin Medical Center ( Site 0081), Petah Tikva
RECRUITING
Sheba Medical Center ( Site 0080), Ramat Gan
RECRUITING
Centro de Estudios Clínicos SAGA ( Site 0033), Santiago
RECRUITING
FALP ( Site 0031), Santiago
RECRUITING
Pontificia Universidad Catolica de Chile ( Site 0032), Santiago
RECRUITING
Bradford Hill Centro de Investigaciones Clinicas ( Site 0030), Santiago
RECRUITING
John Theurer Cancer Center at Hackensack University Medical Center ( Site 1009), Hackensack
RECRUITING
Cancer Institute Hospital of JFCR ( Site 0192), Koto
RECRUITING
Osaka International Cancer Institute ( Site 0191), Osaka
RECRUITING
Radboudumc ( Site 0091), Nijmegen
RECRUITING
Nederlands Kanker Instituut - Antoni van Leeuwenhoek - NKI-AVL ( Site 0090), Amsterdam
RECRUITING
Amsterdam UMC, locatie VUmc ( Site 0093), Amsterdam
RECRUITING
Erasmus Medisch Centrum ( Site 0092), Rotterdam
RECRUITING
Seoul National University Hospital ( Site 0150), Seoul
RECRUITING
Severance Hospital Yonsei University Health System ( Site 0151), Seoul
RECRUITING
Asan Medical Center ( Site 0153), Seoul
RECRUITING
Samsung Medical Center ( Site 0152), Seoul
RECRUITING
Institut Català d'Oncologia - L'Hospitalet ( Site 0113), L'Hospitalet de Llobregat
RECRUITING
HOSPITAL CLÍNIC DE BARCELONA ( Site 0112), Barcelona
RECRUITING
Ankara Bilkent Şehir Hastanesi. ( Site 0131), Çankaya
RECRUITING
Ankara University Health Practice and Research Hospitals ( Site 0134), Ankara
Merck Sharp & Dohme LLC
INDUSTRY